Pain drug and rep hiring timeline pushed?

Discussion in 'Heron Therapeutics' started by anonymous, Jan 24, 2019 at 10:33 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Gov't shutdown continuing seems like it could start having an impact on FDA drug approval reviews, so makes me wonder if pain drug approval will be pushed back beyond the April 30 target date. And geez, we know from the Sustol debacle that Heron and the FDA have had some issues with stated timelines, and communicating those. With a delay, however long, I'd imagine that contingent offers for the pain field force get put on hold as well? Would seem to make sense. Again, this is all dependent on the gov't shutdown continuing. Barry needs to give Trump a call!
     

  2. anonymous

    anonymous Guest

    op sounds like an analyst with an ax to grind
     
  3. anonymous

    anonymous Guest

    Another shutdown looming!